What Happened?
Shares of clinical research company Fortrea Holdings (NASDAQ: FTRE) jumped 6.1% in the afternoon session after Evercore ISI Group raised its price target on the company to $11.00 from a previous $7.00.
The firm maintained its 'In-Line' rating, which typically means the stock is expected to perform similarly to its industry peers. This adjustment by analyst Elizabeth Anderson represented a significant increase of over 57%. While the rating itself was not an upgrade, the substantial price target revision suggested a more positive outlook on the company's future stock performance from the analyst firm.
Is now the time to buy Fortrea? Access our full analysis report here.
What Is The Market Telling Us
Fortrea’s shares are extremely volatile and have had 65 moves greater than 5% over the last year. In that context, today’s move indicates the market considers this news meaningful but not something that would fundamentally change its perception of the business.
The previous big move we wrote about was 13 days ago when the stock dropped 6.3% as negative news weighed on the broader healthcare sector, including a new U.S. government investigation into medical equipment imports and a report detailing potential revenue losses from expiring tax credits. The U.S. Commerce Department initiated an investigation into the national security implications of importing a wide range of healthcare products, from surgical masks to pacemakers. This review raised the possibility of future tariffs or quotas on these goods.
Fortrea is down 47.1% since the beginning of the year, and at $9.87 per share, it is trading 58.4% below its 52-week high of $23.73 from December 2024. Investors who bought $1,000 worth of Fortrea’s shares at the IPO in June 2023 would now be looking at an investment worth $328.05.
Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we’ve identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link.
